Neko Well being has raised $700 million to increase its AI physique scans in the United States, beginning with a clinic in New York. The corporate’s preventive screening service combines medical imaging, blood checks, proprietary sensors, and clinician overview.
The Collection C spherical was led by Lightspeed Enterprise Companions and co-led by O.G. Enterprise Companions. Current traders Atomico, Common Catalyst, and Lakestar participated, alongside new backers together with Liberty Metropolis Ventures, Constructive Sum, and BDT & MSD.
David Ofer of O.G. Enterprise Companions will be part of Neko’s board, topic to regulatory approval.
The most recent spherical brings Neko’s disclosed funding since 2023 to greater than $1 billion. The corporate raised $65 million in a Collection A spherical in 2023 and one other $260 million in January 2025.
The spherical additionally included investments from Meta chief govt Mark Zuckerberg and Priscilla Chan, former tennis participant Maria Sharapova, musician will.i.am, and former footballer Thierry Henry. Current particular person traders embrace Reddit co-founder Alexis Ohanian and actor Zoë Saldaña.
How Neko Well being’s AI physique scans work
Neko operates clinics that mix full-body scans, blood checks, synthetic intelligence, and custom-built medical gear. The service screens prospects for potential indicators of circumstances together with pores and skin most cancers, heart problems, and diabetes.
The corporate describes the service as a 60-minute, non-invasive, and radiation-free well being evaluation. It makes use of proprietary sensors and blood evaluation to look at pores and skin circumstances, blood abnormalities, pre-diabetes indicators, and threat components related to metabolic syndrome, stroke, and coronary heart assault.
The scan additionally consists of an electrocardiogram, arterial measurements, body-composition evaluation, and greater than 2,000 high-resolution pictures used to map a buyer’s pores and skin. Blood samples are processed at the clinic, permitting the outcomes to be reviewed throughout the similar go to.
Outcomes are mentioned throughout an in-person session with a medical skilled.
Lots of the measurements, together with blood strain, blood glucose, ldl cholesterol, electrocardiogram knowledge, and pores and skin assessments, are already obtainable via standard healthcare providers. Neko’s mannequin combines them with proprietary imaging, automated knowledge assortment, on-site blood processing, and a clinician session in a single appointment.
The corporate’s public scientific supplies reviewed for this article do not embrace a comparative research exhibiting whether or not this mixed method improves scientific outcomes or cost-effectiveness in contrast with established preventive-care pathways.
Neko stated the funding will assist the opening of clinics in New York and different US cities. It has not recognized the further places or supplied an in depth growth schedule.
A waitlist for the New York clinic is open on the firm’s web site. Neko has not disclosed how a lot its US scans will value.
The corporate at present operates eight clinics throughout the UK and Sweden, together with two in Stockholm, one every in Manchester and Birmingham, and 4 in London: Marylebone, Spitalfields, Covent Backyard, and Victoria.
A scan prices £299 in the UK and a couple of,750 Swedish kronor in Sweden, equal to about $400 and $285.
Neko stated it has accomplished 100,000 scans since launching its service in 2023. Greater than 350,000 folks have registered for a scan or joined its waitlists.
In accordance to the firm, 75% of shoppers e-book and prepay for an additional scan at the finish of their appointment.
The repeat-booking mannequin permits clinicians to examine measurements and pores and skin pictures over time. Public information reviewed for this article does not embrace proof establishing whether or not annual screening is the applicable interval for each age or threat group.
Based in 2018 by Spotify co-founder Daniel Ek and chief govt Hjalmar Nilsonne, Neko operated largely outdoors public view till launching its service in 2023.
Nilsonne stated a part of the new capital will fund additional analysis and growth into preventive screening know-how.
Neko not too long ago added body-composition measurements and clinician evaluations of wearable-device knowledge throughout its clinics. It has additionally launched up to date variations of its Derma, Echo, and Spectrum medical gadgets, which gather information relating to pores and skin, coronary heart operate, and circulation.
The corporate stated the newer gear captures a bigger quantity of well being knowledge and automates extra elements of the scanning course of. It plans to deploy the gadgets throughout its clinics in the coming months.
The clinic-based mannequin requires proprietary gear, blood-processing capability, medical personnel, and specialist overview for some findings. Neko stated its seven-room Covent Backyard clinic was designed to assist tens of 1000’s of scans yearly, nevertheless it has not disclosed capability or staffing figures for its deliberate US places.
US regulation and entry
FDA data present that two of Neko’s internally developed gadgets acquired clearance via the company’s 510(okay) pathway in Might 2026. Derma-2 was cleared as an adjunctive telethermographic system, whereas Spectrum-2 was cleared as a tissue-saturation oximeter utilized in cardiovascular measurements.
The clearances apply to the specified gadgets and their meant makes use of, moderately than to the full Neko Well being Scan as a single FDA-approved screening service.
Neko describes its US clinics as preventive well being and wellness suppliers moderately than full-service medical practices. Its privateness discover advises prospects to proceed seeing their present clinicians for diagnoses and therapy, together with for circumstances recognized via a Neko scan.
The corporate says specialist clinicians, together with dermatologists and cardiologists, overview findings that require additional examination. Observe-up appointments, referral letters, and introductions to outdoors specialists are included when really useful by a Neko clinician.
Neko’s US clinics do not at present take part in medical health insurance plans, and the firm says most of its providers are not coated by a payer. Prospects are subsequently anticipated to pay straight for the preliminary evaluation.
The corporate has not disclosed what prospects would pay for diagnostic checks or therapy delivered by external healthcare suppliers. It has additionally not introduced its US value or whether or not employers, insurers, or different organisations will subsidise entry to the service.
Questions over scientific proof
Publicly obtainable information reviewed for this article does not embrace a accomplished peer-reviewed research validating the full screening service. A research registered on ClinicalTrials.gov is evaluating the suitability of Neko’s multimodal skin-imaging know-how for screening and diagnostic-support functions, together with pores and skin most cancers and Raynaud’s phenomenon.
The trial stays an ongoing analysis and does not set up the scientific efficiency of the full Neko Well being Scan.
Neko’s public supplies reviewed for this article do not disclose how usually its scans produce false-positive findings, what number of prospects endure further procedures, or what number of flagged abnormalities are later thought-about clinically unimportant.
The corporate’s US privateness discover identifies an AI dictation system used to summarise medical data, questionnaires, scan knowledge, and scientific conversations, and to draft studies. Neko says clinicians overview studies produced utilizing the system.
Public information does not present a whole breakdown of which scan measurements or classifications rely on AI, standard software program, or direct scientific evaluation. It additionally does not state that AI independently diagnoses the circumstances coated by the service.
The FDA clearances for particular person gadgets do not set up the efficiency of each algorithm used to mix or interpret the ensuing knowledge. Public supplies reviewed for this article do not embrace detailed real-world efficiency figures for every AI system utilized in the screening course of.
Neko’s reported health-outcome knowledge is primarily based on 1,469 prospects who accomplished a second scan roughly one 12 months after their first. The corporate stated the group recorded enhancements in blood strain, ldl cholesterol, and blood sugar, whereas physique weight remained broadly steady.
The scans in the evaluation had been carried out at Neko’s Stockholm clinics. The corporate divided the outcomes right into a basic group, a wholesome group, and teams protecting prospects with hypertension, pre-diabetes, or diabetes.
Neko stated the evaluation was not a scientific research and did not embrace a management group. Prospects might have began therapy or modified their behaviour between appointments, so the figures do not set up that the scans prompted the reported enhancements.
The evaluation solely coated prospects who returned for a second privately bought scan. Neko did not publish demographic information exhibiting how that group compares with its wider buyer base or the basic inhabitants.
The corporate did not disclose its valuation following the newest spherical. The Monetary Occasions, citing unnamed sources, reported that Neko is now valued at about $7 billion.
(Photograph by Wonderlane)
See additionally: NHS AI blood test could reduce invasive womb cancer checks
Need to be taught extra about AI and large knowledge from trade leaders? Take a look at AI & Big Data Expo going down in Amsterdam, California, and London. The excellent occasion is a part of TechEx and is co-located with different main know-how occasions, click on here for extra information.
AI Information is powered by TechForge Media. Discover different upcoming enterprise know-how occasions and webinars here.
Disclaimer: This article is sourced from external platforms. OverBeta has not independently verified the information. Readers are advised to verify details before relying on them.
